Products for Research Use Only
RegisterLogin

Docaravimab

CAT: 0804-HY-P99856Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99856Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies[1].
CAS Number
2247196-23-0
UNSPSC
12352203
Target
RABV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/docaravimab.html
Solubility
10 mM in DMSO
Smiles
[Docaravimab]
References & Citations
[1]Wilkinson I, et, al. Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names. MAbs. 2022 Jan-Dec;14 (1) :2123299.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T77161Docaravimab
MBS1564061-01Research Grade Docaravimab
GTR18338246Docaravimab Antibody
E55B0664Docaravimab (Reference antibody)
ICH5484-5mgDocaravimab Biosimilar - Research Grade
GTR18780543-01(Docaravimab) Biosimilar Reference Antibody
21-903Docaravimab - Research Grade Biosimilar
GTR18697691-01Docaravimab Mouse Monoclonal Antibody
A135315Docaravimab Biosimilar (Monoclonal, IgG2b, kappa)
GTR18117755Docaravimab - Research Grade Biosimilar Antibody

Popular Products